Interim Analysis Of A Registration Enabling Study Of Pivekimab Sunirine (Pvek, Imgn632) A Cd123-Targeting Antibody-Drug Conjugate, In Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (Bpdcn)
Pivekimab Sunirine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim Analysis Of A Registration Enabling Study Of Pivekimab Sunirine (Pvek, Imgn632) A Cd123-Targeting Antibody-Drug Conjugate, In Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (Bpdcn) ### Output: Pivekimab Sunirine